Serum Biomarker Analysis in Pediatric ADHD: Implications of Homocysteine, Vitamin B12, Vitamin D, Ferritin, and Iron Levels

Overview

Journal Children (Basel)

Specialty Health Services

Date 2024 Apr 27

PMID 38671715

Authors

Tanja Lukovac

Olivera Aleksic Hil

Milka Popovic

Vitomir Jovanovic

Tatjana Savic

Aleksandra M Pavlovic

Dragan Pavlovic

Affiliations

Soon will be listed here.

Abstract

The current diagnosis of attention deficit hyperactivity disorder (ADHD) is based on history, clinical observation, and behavioral tests. There is a high demand to find biomarkers for the diagnosis of ADHD. The aim of this study is to analyze the serum profiles of several biomarkers, including homocysteine (Hcy), vitamin B12, vitamin D, ferritin, and iron, in a cohort of 133 male subjects (6.5-12.5 years), including 67 individuals with an ADHD diagnosis based on DSM-V criteria and 66 age-matched healthy boys (healthy controls, HC). Assessments for ADHD included the Iowa Conners' Teacher Rating Scale (CPRS) and the ADHDT test, as well as cognitive assessments using the Wechsler Intelligence Scale for Children-Revised (WISC-R) and the TROG-2 language comprehension test. Hcy and iron were quantified using spectrophotometry, while vitamin B12 and total 25-hydroxy vitamin D levels were determined using an electrochemiluminescence immunoassay (ECLIA) and ferritin was measured using a particle-enhanced immunoturbidimetric assay. The results showed significantly increased Hcy levels and decreased vitamin B12 levels in ADHD patients compared to HCs. Multiple logistic regression analysis indicated that Hcy is a potential prognostic indicator for ADHD. These results suggest that elevated homocysteine and decreased vitamin B12 may serve as markers for the diagnosis and prognosis of ADHD.

Citing Articles

Nutritional management and autism spectrum disorder: A systematic review.

Al-Beltagi M World J Clin Pediatr. 2024; 13(4):99649.

PMID: 39654662 PMC: 11572612. DOI: 10.5409/wjcp.v13.i4.99649.

References

Wang Y, Huang L, Zhang L, Qu Y, Mu D . Iron Status in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. PLoS One. 2017; 12(1):e0169145. PMC: 5207676. DOI: 10.1371/journal.pone.0169145. View

Santa-Marina L, Lertxundi N, Andiarena A, Irizar A, Sunyer J, Molinuevo A . Maternal Ferritin Levels during Pregnancy and ADHD Symptoms in 4-Year-Old Children: Results from the INMA-INfancia y Medio Ambiente (Environment and Childhood) Prospective Birth Cohort Study. Int J Environ Res Public Health. 2020; 17(21). PMC: 7659477. DOI: 10.3390/ijerph17217704. View

Toomey S, Sox C, Rusinak D, Finkelstein J . Why do children with ADHD discontinue their medication?. Clin Pediatr (Phila). 2012; 51(8):763-9. DOI: 10.1177/0009922812446744. View

Bressenot A, Pooya S, Bossenmeyer-Pourie C, Gauchotte G, Germain A, Chevaux J . Methyl donor deficiency affects small-intestinal differentiation and barrier function in rats. Br J Nutr. 2012; 109(4):667-77. DOI: 10.1017/S0007114512001869. View

Degremont A, Jain R, Philippou E, Latunde-Dada G . Brain iron concentrations in the pathophysiology of children with attention deficit/hyperactivity disorder: a systematic review. Nutr Rev. 2020; 79(5):615-626. DOI: 10.1093/nutrit/nuaa065. View

Liu D, Xie Z, Gu P, Li X, Zhang Y, Wang X . Cry1Δ11 mutation induces ADHD-like symptoms through hyperactive dopamine D1 receptor signaling. JCI Insight. 2023; 8(16). PMC: 10543712. DOI: 10.1172/jci.insight.170434. View

Altun H, Sahin N, Belge Kurutas E, Gungor O . Homocysteine, Pyridoxine, Folate and Vitamin B12 Levels in Children with Attention Deficit Hyperactivity Disorder. Psychiatr Danub. 2018; 30(3):310-316. DOI: 10.24869/psyd.2018.310. View

Neyestani T, Hajifaraji M, Omidvar N, Eshraghian M, Shariatzadeh N, Kalayi A . High prevalence of vitamin D deficiency in school-age children in Tehran, 2008: a red alert. Public Health Nutr. 2011; 15(2):324-30. DOI: 10.1017/S1368980011000188. View

Sharma A, Couture J . A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Ann Pharmacother. 2013; 48(2):209-25. DOI: 10.1177/1060028013510699. View

10.

Ho P, Ortiz D, Rogers E, Shea T . Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res. 2002; 70(5):694-702. DOI: 10.1002/jnr.10416. View

11.

De la Torre-Iturbe S, Vazquez-Roque R, de la Cruz-Lopez F, Flores G, Garces-Ramirez L . Dendritic and behavioral changes in rats neonatally treated with homocysteine; A proposal as an animal model to study the attention deficit hyperactivity disorder. J Chem Neuroanat. 2021; 119:102057. DOI: 10.1016/j.jchemneu.2021.102057. View

12.

Meyer T, Becker A, Sundermann J, Rothenberger A, Herrmann-Lingen C . Attention deficit-hyperactivity disorder is associated with reduced blood pressure and serum vitamin D levels: results from the nationwide German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Eur Child Adolesc Psychiatry. 2016; 26(2):165-175. DOI: 10.1007/s00787-016-0852-3. View

13.

Fuller J, Burrell M, Yee A, Liyanagama K, Lipski J, Wickens J . Role of homeostatic feedback mechanisms in modulating methylphenidate actions on phasic dopamine signaling in the striatum of awake behaving rats. Prog Neurobiol. 2019; 182:101681. DOI: 10.1016/j.pneurobio.2019.101681. View

14.

Mohammadpour N, Jazayeri S, Tehrani-Doost M, Djalali M, Hosseini M, Effatpanah M . Effect of vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: A randomized, double blind, placebo-controlled trial. Nutr Neurosci. 2016; 21(3):202-209. DOI: 10.1080/1028415X.2016.1262097. View

15.

Eyles D, Smith S, Kinobe R, Hewison M, McGrath J . Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2004; 29(1):21-30. DOI: 10.1016/j.jchemneu.2004.08.006. View

16.

Konofal E, Lecendreux M, Arnulf I, Mouren M . Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2004; 158(12):1113-5. DOI: 10.1001/archpedi.158.12.1113. View

17.

Dunn G, Nigg J, Sullivan E . Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. Pharmacol Biochem Behav. 2019; 182:22-34. PMC: 6855401. DOI: 10.1016/j.pbb.2019.05.005. View

18.

Pinto S, Correia-de-Sa T, Sampaio-Maia B, Vasconcelos C, Moreira P, Ferreira-Gomes J . Eating Patterns and Dietary Interventions in ADHD: A Narrative Review. Nutrients. 2022; 14(20). PMC: 9608000. DOI: 10.3390/nu14204332. View

19.

Chiang H, Chen Y, Shang C, Tseng W, Gau S . Different neural substrates for executive functions in youths with ADHD: a diffusion spectrum imaging tractography study. Psychol Med. 2016; 46(6):1225-38. DOI: 10.1017/S0033291715002767. View

20.

Chaplin G, Jablonski N . Vitamin D and the evolution of human depigmentation. Am J Phys Anthropol. 2009; 139(4):451-61. DOI: 10.1002/ajpa.21079. View